Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities.
A comparison of treated and untreated patients with growth hormone deficiency revealed that administration of growth hormone reduced lipoprotein lipase and hepatic lipase activities, total cholesterol, and high-density lipoprotein cholesterol concentrations. The possible significance of these results is discussed.
D000293:Adolescent; D002648:Child; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL; D004393:Dwarfism, Pituitary / Q000188:drug therapy / Q000201:enzymology; D005260:Female; D013006:Growth Hormone / Q000627:therapeutic use*; D006493:Heparin; D006801:Humans; D008049:Lipase / Q000378:metabolism*; D008071:Lipoprotein Lipase / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008099:Liver / Q000201:enzymology*; D008297:Male
D008076:Cholesterol, HDL; D008075:Lipoproteins, HDL; D013006:Growth Hormone; D006493:Heparin; D002784:Cholesterol; D008049:Lipase; D008071:Lipoprotein Lipase